drug
as of 2026-07-01Lithium
lithium
MeSH D008094
at a glance
small molecule
Pre-approval / investigational in the US
Developed by Dr. Inge Winter
6 trials in the graph
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Trials
6
Intensified Pharmacological Treatment for Schizophrenia, Major Depressive Disorder and Bipolar Depression After a First-time Treatment Failure
NCT05603104Phase 3Recruiting
Treatment of Psychosis and Agitation in Alzheimer's Disease
NCT02129348Phase 2Completed
Pharmacovigilance in Gerontopsychiatric Patients
NCT02374567Phase 3Terminated
Comparison of Combination Olanzapine+Lithium or Chlorpromazine+Lithium in Treatment of First Manic Episode With Psychotic Features
NCT00202293Phase 4Completed
Treatment of Mania Symptoms With Drug Therapy
NCT00183443Phase 3Completed
Systematic Treatment Enhancement Program for Bipolar Disorder (STEP-BD)
NCT00012558—Completed
KOLs & investigators
6
Trisha Suppes, MD, PhDKOL score 7
Helge Frieling, Prof., MDKOL score 5
Professor Gary Donohoe, Ph.D.KOL score 5
Michael C Davis, M.D., Ph.D.KOL score 5
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here
developer
company
trial
indication
KOL
Trisha Suppes, MD, PhD
personKOL score 7
Helge Frieling, Prof., MD
personKOL score 5
Professor Gary Donohoe, Ph.D.
personKOL score 5
Michael C Davis, M.D., Ph.D.
personKOL score 5